122 related articles for article (PubMed ID: 27769359)
1. Regulation of gene expression in human cancers by TRIM24.
Appikonda S; Thakkar KN; Barton MC
Drug Discov Today Technol; 2016 Mar; 19():57-63. PubMed ID: 27769359
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion.
Appikonda S; Thakkar KN; Shah PK; Dent SYR; Andersen JN; Barton MC
J Biol Chem; 2018 May; 293(19):7476-7485. PubMed ID: 29523690
[TBL] [Abstract][Full Text] [Related]
3. TRIM24 links a non-canonical histone signature to breast cancer.
Tsai WW; Wang Z; Yiu TT; Akdemir KC; Xia W; Winter S; Tsai CY; Shi X; Schwarzer D; Plunkett W; Aronow B; Gozani O; Fischle W; Hung MC; Patel DJ; Barton MC
Nature; 2010 Dec; 468(7326):927-32. PubMed ID: 21164480
[TBL] [Abstract][Full Text] [Related]
4. TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage.
Jain AK; Allton K; Duncan AD; Barton MC
Mol Cell Biol; 2014 Jul; 34(14):2695-709. PubMed ID: 24820418
[TBL] [Abstract][Full Text] [Related]
5. TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression.
Fong KW; Zhao JC; Song B; Zheng B; Yu J
Nat Commun; 2018 Nov; 9(1):5007. PubMed ID: 30479348
[TBL] [Abstract][Full Text] [Related]
6. Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer.
Shah VV; Duncan AD; Jiang S; Stratton SA; Allton KL; Yam C; Jain A; Krause PM; Lu Y; Cai S; Tu Y; Zhou X; Zhang X; Jiang Y; Carroll CL; Kang Z; Liu B; Shen J; Gagea M; Manu SM; Huo L; Gilcrease M; Powell RT; Guo L; Stephan C; Davies PJ; Parker-Thornburg J; Lozano G; Behringer RR; Piwnica-Worms H; Chang JT; Moulder SL; Barton MC
Nat Commun; 2021 Sep; 12(1):5389. PubMed ID: 34508101
[TBL] [Abstract][Full Text] [Related]
7. Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling.
Xie W; Zhang Y; Wang B; Hu Y; Zhan B; Wei F; Tang J; Lian J
Cancer Med; 2020 Sep; 9(17):6367-6376. PubMed ID: 32677374
[TBL] [Abstract][Full Text] [Related]
8. Novel insights into the recognition of acetylated histone H4 tail by the TRIM24 PHD-Bromo module.
Bardhan I; Barman S; Roy A; Sudhamalla B
Biochem J; 2023 May; 480(9):629-647. PubMed ID: 37075063
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the TRIM24 E3 Ubiquitin Ligase is Linked to Genetic Instability and Predicts Unfavorable Prognosis in Prostate Cancer.
Höflmayer D; Fraune C; Hube-Magg C; Simon R; Schroeder C; Büscheck F; Möller K; Dum D; Weidemann S; Wittmer C; Schlomm T; Huland H; Heinzer H; Graefen M; Haese A; Sauter G; Burandt E; Clauditz TS; Steurer S; Minner S; Wilczak W; Polonski A
Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):e29-e38. PubMed ID: 33491944
[TBL] [Abstract][Full Text] [Related]
10. Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands.
Gechijian LN; Buckley DL; Lawlor MA; Reyes JM; Paulk J; Ott CJ; Winter GE; Erb MA; Scott TG; Xu M; Seo HS; Dhe-Paganon S; Kwiatkowski NP; Perry JA; Qi J; Gray NS; Bradner JE
Nat Chem Biol; 2018 Apr; 14(4):405-412. PubMed ID: 29507391
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of tripartite motif containing 24 in various human solid malignant neoplasms: An updated meta-analysis and systematic review.
Xue Y; Ge W; Shi W; Huang W; Wang R
Medicine (Baltimore); 2021 Dec; 100(51):e28383. PubMed ID: 34941167
[TBL] [Abstract][Full Text] [Related]
12. TRIM24 links glucose metabolism with transformation of human mammary epithelial cells.
Pathiraja TN; Thakkar KN; Jiang S; Stratton S; Liu Z; Gagea M; Shi X; Shah PK; Phan L; Lee MH; Andersen J; Stampfer M; Barton MC
Oncogene; 2015 May; 34(22):2836-45. PubMed ID: 25065590
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological targeting of Tripartite Motif Containing 24 for the treatment of glioblastoma.
Han M; Sun Y
J Transl Med; 2021 Dec; 19(1):505. PubMed ID: 34886858
[TBL] [Abstract][Full Text] [Related]
14. Trim24 targets endogenous p53 for degradation.
Allton K; Jain AK; Herz HM; Tsai WW; Jung SY; Qin J; Bergmann A; Johnson RL; Barton MC
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11612-6. PubMed ID: 19556538
[TBL] [Abstract][Full Text] [Related]
15. Histone onco-modifications.
Füllgrabe J; Kavanagh E; Joseph B
Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Modification Induced Specific Recognition between Histone and TRIM24 via Fluctuation Correlation Network Analysis.
Zhang J; Luo H; Liu H; Ye W; Luo R; Chen HF
Sci Rep; 2016 Apr; 6():24587. PubMed ID: 27079666
[TBL] [Abstract][Full Text] [Related]
17. Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor.
Palmer WS; Poncet-Montange G; Liu G; Petrocchi A; Reyna N; Subramanian G; Theroff J; Yau A; Kost-Alimova M; Bardenhagen JP; Leo E; Shepard HE; Tieu TN; Shi X; Zhan Y; Zhao S; Barton MC; Draetta G; Toniatti C; Jones P; Geck Do M; Andersen JN
J Med Chem; 2016 Feb; 59(4):1440-54. PubMed ID: 26061247
[TBL] [Abstract][Full Text] [Related]
18. Chromatin regulators with tumor suppressor properties and their alterations in human cancers.
Shu XS; Li L; Tao Q
Epigenomics; 2012 Oct; 4(5):537-49. PubMed ID: 23130835
[TBL] [Abstract][Full Text] [Related]
19. Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha.
Khetchoumian K; Teletin M; Tisserand J; Mark M; Herquel B; Ignat M; Zucman-Rossi J; Cammas F; Lerouge T; Thibault C; Metzger D; Chambon P; Losson R
Nat Genet; 2007 Dec; 39(12):1500-6. PubMed ID: 18026104
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.
Bennett J; Fedorov O; Tallant C; Monteiro O; Meier J; Gamble V; Savitsky P; Nunez-Alonso GA; Haendler B; Rogers C; Brennan PE; Müller S; Knapp S
J Med Chem; 2016 Feb; 59(4):1642-7. PubMed ID: 25974391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
